Botanical Nomenclature in Pharmacovigilance and a Recommendation for Standardisation

• Nomenclature of plants in pharmacology can be presented by pharmaceutical names or scientific names in the form of Linnaean binomials. In this paper, positive and negative aspects of both systems are discussed in the context of the scientific nomenclatural framework and the systems’ practical applicability. The Uppsala Monitoring Centre (UMC) runs the WHO Programme for International Drug Monitoring and is responsible for the WHO Adverse Drug Reaction (ADR) database that currently contains 3.6 million records WHO Adverse Drug Reaction database. In order for the UMC to monitor pharmacovigilance through ADRs to herbal medicine products the following species nomenclatural criteria are important: (i) the name should indicate only one species of plant; (ii) the source for this name must be authoritative; (iii) the name should indicate which part of the plant is used. Based on these criteria, the UMC investigated four options: (i) adopt main names used in recognised (inter-) national pharmacopoeias or authoritative publications; (ii) adopt option 1, but cite the publication for all names in abbreviated form; (iii) three-part pharmaceutical names consisting of Latinised part name plus Latinised genus name, plus Latinised specific epithet; (iv) scientific binomial names, optionally with author and plant part used. The UMC has selectedchosen for the latter option and willas its adoption utilizes the scientific botanical nomenclature as defined by the International Code of Botanical Nomenclature.

Ämnesord

NATURVETENSKAP  -- Biologi -- Biologisk systematik (hsv//swe)

NATURAL SCIENCES  -- Biological Sciences -- Biological Systematics (hsv//eng)

Nyckelord

Systematics and phylogenetics

Systematik och fylogeni

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)